Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

ImmunoCellular Therapeutics (OTCBB: IMUC) announced today that Manish Singh, Ph.D., President and CEO, will be presenting at the Cancer Stem Cells Conference, a leading industry event, on Wednesday, March 24th at 2:00 p.m. eastern time.

At the event, Dr. Singh will present clinical data on ICT-107 and developmental plans for the candidate, preclinical data on ICT-121 and the mechanism of dendritic cell based vaccination, during a session entitled, “Translating Research into Drug Development I.”

Also presenting during the session will be executives from OncoMed, Geron, and Micromet. The conference, hosted by Biorbis, a division of Hanson Wade, will take place at Le Meridien Hotel in Cambridge, MA.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Air pollution linked to head and neck cancer risk